The commonly used immunization coverage and dropout rate indicators, and what they may indicate, are summarised below:
| Indicator (%) | What it may indicate |
|---|---|
| Penta1 coverage | Availability of, access to, and initial use of immunization services by parents or caregivers |
| Penta3 coverage | Continuity of use by parents or caregivers |
| Measles coverage | Protection against a disease of major public health importance |
| Penta1 to Penta3 dropout | Access to the service by parents or caregivers, and quality of communication by health professionals — this is an international dropout indicator |
| Penta1 to measles dropout | Utilisation of health services by parents or caregivers, and the perceived quality of the service in the community — this is an international dropout indicator |
| TT1 coverage during pregnancy | Availability of, access to, and use of immunization services by pregnant women |
| TT2+ (TT3, TT4 or TT5 coverage)
TT2+ (or TT+2) means the women received more than two doses of TT vaccine. |
Continuity of use, client satisfaction and capability of the system to deliver a series of immunizations to women |
| Fully-immunized children (FIC) | Capability of the system to provide all vaccines in the childhood schedule at the appropriate age, and at the appropriate interval between doses in the first year of life; also measures public demand and perceived quality of services |
The next table below shows you how to assess whether low immunization coverage or high dropout rates are due to a problem of access (coming to the immunization services) or to a problem of utilisation (usage of immunization services). You should use the results of your assessment to identify and prioritise problems in your immunization programme, and work out possible solutions.
| Observation at health facility level | Problems identified |
|---|---|
| High Penta1 coverage and low dropout rate | No problem |
| High Penta1 coverage and high dropout rate | Utilisation problem |
| Low Penta1 coverage and low dropout rate | Access problem |
| Low Penta1 coverage and high dropout rate | Access and utilisation problems |